ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NKTX Nkarta Inc

6.55
-0.03 (-0.46%)
May 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Nkarta Inc NKTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.03 -0.46% 6.55 18:48:13
Open Price Low Price High Price Close Price Previous Close
6.69 6.31 6.785 6.55 6.58
more quote information »

Recent News

Date Time Source Heading
5/09/202415:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202415:04EDGAR2Form 8-K - Current report
5/09/202415:01GLOBENkarta Reports First Quarter 2024 Financial Results and..
4/03/202415:02GLOBENkarta to Participate in Upcoming Investor Conferences
3/25/202405:30GLOBENkarta Announces Pricing of $240 Million Underwritten..
3/21/202415:01GLOBENkarta Reports Fourth Quarter and Full Year 2023 Financial..
3/05/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202415:32EDGAR2Form 144 - Report of proposed sale of securities
2/28/202407:01GLOBENkarta to Participate in Upcoming Investor Conferences
2/14/202420:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202415:20EDGAR2Form 144 - Report of proposed sale of securities
2/09/202405:38EDGAR2Form SC 13D/A - General statement of acquisition of..
1/18/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202407:50EDGAR2Form 8-K - Current report
1/03/202415:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/09/202319:31GLOBENkarta Presents NKX101 Clinical Data at the 2023 American..
11/13/202307:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/09/202315:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:06EDGAR2Form 8-K - Current report
11/09/202315:02GLOBENkarta Reports Third Quarter 2023 Financial Results and..
11/07/202307:02GLOBENkarta to Participate at Upcoming Investor Conferences
10/27/202315:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/17/202311:00DJNNkarta's Stock Climbs 28% After FDA Approves Drug..
10/17/202310:47PRNUSLupus Therapeutics Announces Partnership to Support the..
10/17/202306:06EDGAR2Form 8-K - Current report
10/17/202306:01GLOBENkarta Receives FDA Clearance of IND Application for NKX019..
10/16/202315:07EDGAR2Form 8-K - Current report
10/16/202315:01GLOBENkarta to Host Conference Call on Tuesday, October 17 at 8am..
8/23/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202306:05EDGAR2Form 8-K - Current report
8/10/202306:01GLOBENkarta Reports Second Quarter 2023 Financial Results and..
8/03/202307:02GLOBENkarta to Participate at Upcoming Investor Conference
7/05/202315:09EDGAR2Form 8-K - Current report
7/05/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/05/202315:02GLOBENkarta Appoints Alyssa Levin Chief Financial and Business..
6/27/202306:01GLOBENkarta Updates Clinical Progress of CAR-NK Cell Therapy..
6/26/202315:01GLOBENkarta to Host Conference Call to Discuss Updated Clinical..
6/10/202309:47GLOBENkarta Presents NKX019 Clinical Data at the European..